Compounds > h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide
Page last updated: 2024-09-03

h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide and epidermal growth factor

h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide has been researched along with epidermal growth factor in 1 studies

Compound Research Comparison

Studies
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Trials
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Recent Studies (post-2010)
(h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide)		Studies
(epidermal growth factor)		Trials
(epidermal growth factor)		Recent Studies (post-2010) (epidermal growth factor)
60024,1552174,699

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kessler, TL; Markus, G1

Other Studies

1 other study(ies) available for h-norleucyl-hexahydrotyrosyl-lysine-4-nitroanilide and epidermal growth factor

ArticleYear
Epidermal growth factor and 12-tetradecanoyl phorbol 13-acetate induction of urokinase in A431 cells.
    Seminars in thrombosis and hemostasis, 1991, Volume: 17, Issue:3

    Topics: Chromogenic Compounds; Electrophoresis, Gel, Two-Dimensional; Enzyme Induction; Epidermal Growth Factor; Humans; Oligopeptides; Phosphorylation; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tyrosine; Urokinase-Type Plasminogen Activator

1991